BRD4 was shown to be occupied at the Notch1 promoter site, thus controlling the Notch1 signaling pathway that is involved in regulating the self-renewal capacity of glioma stem cells and their tumorigenicity [55]. The gene discussed is NOTCH1; the disease is central nervous system cancer.